Adicet Bio Inc (NASDAQ:ACET)
| 19.24 Delayed Data As of Dec 02 |  +0.66 / +3.55%Today’s Change | 9.54 Today|||52-Week Range 21.87 | +10.01% Year-to-Date |
Latest ACET News | Press Releases
| Wall Street Analysts Think Adicet Bio, Inc. (ACET) Could Surge 72%: Read This Before Placing a Bet Nov 29 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 18.58 |
| Today’s open | 18.36 |
| Day’s range | 18.12 - 19.29 |
| Volume | 23,983 |
| Average volume (3 months) | 552,370 |
| Market cap | $824.5M |
Data as of 4:00pm ET, 12/02/2022
Growth & Valuation
| Earnings growth (last year) | +60.02% |
| Earnings growth (this year) | +23.00% |
| Earnings growth (next 5 years) | +11.78% |
| Revenue growth (last year) | -45.65% |
| P/E ratio | NM |
| Price/Sales | 55.64 |
| Price/Book | 2.52 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AGENAgenus Inc | +0.32 | +12.31% |
| ---- | ||
| ANABAnaptysBio Inc | +0.02 | +0.07% |
| GERNGeron Corp | +0.05 | +2.23% |
Data as of 4:00pm ET, 12/02/2022
Financials
| Next reporting date | March 9, 2023 |
| EPS forecast (this quarter) | -$0.52 |
| Annual revenue (last year) | $9.7M |
| Annual profit (last year) | -$62.0M |
| Net profit margin | -637.19% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
